4 May 2011
Montreal, Quebec, Canada - A new blood test that will diagnose Alzheimer’s disease may soon hit the market, thanks to an innovative study from the Research Institute of the McGill University Health Centre (MUHC).
27 April 2011
Tampa, FL, USA -Cotinine, a compound derived from tobacco, reduced plaques associated with dementia and prevented memory loss in a mouse model of Alzheimer’s disease, a study led by researchers at Bay Pines VA Healthcare System and the University of South Florida found.
13 March 2011
Los Angeles, CA, USA - UCLA researchers have identified a new biomarker that could help them track how effectively the immune system is able to clear the brain of amyloid beta, which forms the plaques considered one of the hallmarks of Alzheimer's disease.
10 January 2011
Abstinence, heavy drinking and binge drinking all associated with increased risk of cognitive impairment
Amsterdam, The Netherlands -- Previous research regarding the association between alcohol consumption and dementia or cognitive impairment in later life suggests that mild to moderate alcohol consumption might be protective of dementia.
9 December 2010
Alzheimer and heart attacks have been found to share common genetic basis. The research leads the way to the first genetic test on developing the risk of the diseases even at a young age.
30 November 2010
Study Suggests Earliest Brain Changes Associated With The Genetic Risk Of Alzheimer’s Disease: May Have Implications for the Development of Prevention Therapies
Glendale, Arizona—What are the earliest brain changes associated with the risk of developing Alzheimer’s disease?
12 November 2010
Amsterdam, The Netherlands and San Antonio, TX, USA – There is growing global concern regarding the potential neurotoxicity of anesthetics. Biophysical and animal model studies have identified molecular changes simulating Alzheimer’s disease (AD) pathology after exposure to inhaled anesthetics.
23 August 2010
Amsterdam, The Netherlands and San Antonio, TX, USA – International publisher IOS Press and the Editors-in-Chief of the Journal of Alzheimer’s Disease (JAD) are pleased to announce that with a 51.04 rating, the Journal has achieved a ranking of #18 on the Index Copernicus Top 10
23 August 2010
Tampa, FL -- A signaling protein released during rheumatoid arthritis dramatically reduced Alzheimer’s disease pathology and reversed the memory impairment of mice bred to develop symptoms of the neurodegenerative disease, a new study by the University of South Florida reports.
13 June 2010
Can Alzheimer’s Disease Be Prevented? Researchers Explore Potential Interventions in a Special Issue of the Journal of Alzheimer’s Disease
Amsterdam, The Netherlands – Although effective treatment for Alzheimer’s disease (AD) has been slow to emerge, there has been substantial progress in identifying AD risk factors and developing treatments that might delay or prevent onset of the disease.